Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID
Jorge Calderón‐Parra, A. Muiño-Míguez, Alejandro David Bendala Estrada, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251340-e0251340
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, et al.
Mycopathologia (2021) Vol. 186, Iss. 6, pp. 739-754
Open Access | Times Cited: 203
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 128
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review
Francesco Vladimiro Segala, Davide Fiore Bavaro, Francesco Di Gennaro, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2110-2110
Open Access | Times Cited: 98
COVID-19-associated mucormycosis: Case report and systematic review
Ahmet Dilek, Reşat Özaras, Şevket Özkaya, et al.
Travel Medicine and Infectious Disease (2021) Vol. 44, pp. 102148-102148
Open Access | Times Cited: 85
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis
Sidra Khan, Syed Shahzad Hasan, Stuart Bond, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 5, pp. 749-772
Open Access | Times Cited: 72
COVID-19 and Antimicrobial Resistance: Data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance—WHONET-Greece (January 2018–March 2021)
Michalis Polemis, Georgia Mandilara, Όλγα Παππά, et al.
Life (2021) Vol. 11, Iss. 10, pp. 996-996
Open Access | Times Cited: 42
Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020–2021: Practice Does Not Follow Policy
Ibrahim Franklyn Kamara, Ajay Kumar, Anna Maruta, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 7, pp. 4005-4005
Open Access | Times Cited: 33
Persistence of resistance: a panel data analysis of the effect of antibiotic usage on the prevalence of resistance
Sakib Rahman, Aaron S. Kesselheim, Aidan Hollis
The Journal of Antibiotics (2023) Vol. 76, Iss. 5, pp. 270-278
Open Access | Times Cited: 22
Semisynthetic Amides of Amphotericin B and Nystatin A1: A Comparative Study of In Vitro Activity/Toxicity Ratio in Relation to Selectivity to Ergosterol Membranes
Anna N. Tevyashova, Svetlana S. Efimova, Alexander I. Alexandrov, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 151-151
Open Access | Times Cited: 18
COVID-19: Impact on prescribing and antimicrobial resistance
Patricia Ruíz-Garbajosa, Rafael Cantón
Revista Española de Quimioterapia (2021) Vol. 34, Iss. Suppl 1, pp. 63-68
Open Access | Times Cited: 35
The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective
Izzati-Nadhirah Mohamad, Calvin Wong, Chii-Chii Chew, et al.
Journal of Pharmaceutical Policy and Practice (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Antibiotic Resistance: A Global Problem and the Need to Do More
Fernanda C. Lessa, Dawn Sievert
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_1, pp. S1-S3
Open Access | Times Cited: 13
COVID-19-associated Mucormycosis: A clinico-epidemiological study
Jaya Chakravarty, Munesh Kumar Gupta, Ragini Tilak, et al.
Journal of Diabetes and its Complications (2022) Vol. 36, Iss. 9, pp. 108284-108284
Open Access | Times Cited: 22
Antibiotic Prescription and In-Hospital Mortality in COVID-19: A Prospective Multicentre Cohort Study
Larisa Pinte, Alexandr Ceasovschih, Cristian‐Mihail Niculae, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 877-877
Open Access | Times Cited: 21
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India
Manickam Ponnaiah, Sivaraman Ganesan, Tarun Bhatnagar, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0272042-e0272042
Open Access | Times Cited: 20
Prevalence, risk factors, and outcomes of secondary infections among hospitalized patients with COVID-19 or post–COVID-19 conditions in Victoria, 2020-2023
Hugh C. Murray, Michael Muleme, Darcie Cooper, et al.
International Journal of Infectious Diseases (2024) Vol. 145, pp. 107078-107078
Open Access | Times Cited: 4
Antibacterial boosting effect of combined antibiotics and wild mushroom (Langermannia bicolor) reduces the survival of multidrug-resistant bacteria
Geovanna Maria de Medeiros Moura, M.T.A. Oliveira, Ana Carolina Justino de Araújo, et al.
Cuadernos de Educación y Desarrollo (2025) Vol. 17, Iss. 1, pp. e7268-e7268
Closed Access
Public knowledge, attitudes, and practices regarding antibiotics use and resistance in Montenegro
Maja Raičević, Snezana Labovic Barjaktarovic, D. Milić, et al.
European Journal of Public Health (2025)
Open Access
The Effect of Antibiotic Use on Intensive Care Unit Admission and Mortality in Inpatients with COVID-19 Diagnosis
Taliha Karakök, Ahmet Doğan, Onur Acar
Düzce Tıp Fakültesi Dergisi (2025), Iss. Early Access
Open Access
The impact of health and technology shifts on antibiotic use among the elderly in Thailand
Nakarin Prasit, Surachai Phimha, Ampawan Nonthamat, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Seasonal variations and the COVID-19 pandemic: impact on antimicrobial stewardship and antibiotic prescribing in a UK secondary care setting to combat antimicrobial resistance—a pilot study
Rasha Abdelsalam-Elshenawy, Nkiruka Umaru, Zoe Aslanpour
Frontiers in Microbiology (2025) Vol. 16
Open Access
Knowledge, attitude, and practice (KAP) of antimicrobial prescription and its resistance among health care providers in the COVID-19 era: A cross sectional study
Nader Nemr, Rania Kishk, Noha M. Abu Bakr Elsaid, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289711-e0289711
Open Access | Times Cited: 10
SHEA statement on antibiotic stewardship in hospitals during public health emergencies
Tamar F. Barlam, Mayar Al Mohajer, Jaffar A. Al‐Tawfiq, et al.
Infection Control and Hospital Epidemiology (2022) Vol. 43, Iss. 11, pp. 1541-1552
Open Access | Times Cited: 16
Coronavirus disease 2019 (COVID-19): Secondary bacterial infections and the impact on antimicrobial resistance during the COVID-19 pandemic
Yelena Markovskaya, Elizabeth M. Gavioli, Jaclyn A. Cusumano, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 15
The burden of Clostridioides difficile on COVID‐19 hospitalizations in the USA
Aalam Sohal, Hunza Chaudhry, Piyush Singla, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 4, pp. 590-597
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top